The NeoIPC Trial, NeoDeco, is a large cluster randomised controlled trial in neonatal intensive care units (NICU) to investigate an Infection Prevention and Control (IPC) intervention in this setting. At the moment, we are looking to define the interventions based on emerging data on effective IPC in NICU.
Sponsored by Penta, the trial will begin with a resistant bacterial colonisation assessment phase. This will help:
- to find out what the levels of colonisation across Europe are
- to determine the optimal strategies for obtaining the required microbiological data.